- MD, Universidad Peruana Cayetano Heredia
- MS, Clinical Epidemiology and Health Services Research Weill Cornell Graduate School of Medical Science
- Residency, University of Alabama at Birmingham
- Fellowship, Hospital for Special Surgery/Weill Cornell Medicine
Education & Training
Dr. Sattui’s work is focused on improving the care of patients living with vasculitis. His research is focused on the assessment of disease biomarkers and the treatment outcomes of patients living with vasculitis such as giant cell arteritis, ANCA-vasculitis, as well as polymyalgia rheumatica (PMR). He is also interested in aging-related outcomes of patients living with vasculitis and PMR, as well as other inflammatory conditions.
In response to the COVID-19 pandemic, Dr. Sattui also became involved in different COVID-19 related research initiatives including the COVID-19 Global Rheumatology Alliance. His work has focused on identifying the impact of COVID-19 on patients with rheumatic diseases as well the use of immunomodulatory therapy for the treatment of severe COVID-19.
Dr. Sattui's clinical focus is the evaluation, management, and care of patients with different forms of vasculitis and polymyalgia rheumatica. He is the director of the UPMC Vasculitis Clinic that if focused on provided timely and multidisciplinary care to patients with these conditions. Dr. Sattui received the Vasculitis Foundation/Vasculitis Clinical Research Consortium Fellowship Award 2019-2021 to support his training on the care of patients with these conditions.
Dr. Sattui is interested in fellow and resident education focused on the treatment of vasculitis and PMR, as well as other complex rheumatic conditions including interstitial lung disease.
